Cargando…
CD73 expression in normal, hyperplastic, and neoplastic thyroid: a systematic evaluation revealing CD73 overexpression as a feature of papillary carcinomas
CD73 converts AMP to adenosine, an immunosuppressive metabolite that promotes tumorigenesis. This study presents a systematic evaluation of CD73 expression in benign, hyperplastic, and neoplastic thyroid. CD73 expression was assessed by immunohistochemistry in 142 thyroid samples. CD73 was expressed...
Autores principales: | Monteiro, Inês, Missiaglia, Edoardo, Sciarra, Amedeo, Santos, João Vasco, Bouilly, Justine, Romero, Pedro, Sempoux, Christine, de Leval, Laurence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298324/ https://www.ncbi.nlm.nih.gov/pubmed/34019179 http://dx.doi.org/10.1007/s00428-021-03100-x |
Ejemplares similares
-
CD73 expression and clinical significance in human metastatic melanoma
por: Monteiro, Inês, et al.
Publicado: (2018) -
CD73 Overexpression Promotes Progression and Recurrence of Papillary Thyroid Carcinoma
por: Jeong, Young Mun, et al.
Publicado: (2020) -
The Roles of CD73 in Cancer
por: Gao, Zhao-wei, et al.
Publicado: (2014) -
The Clinical Significance of CD73 in Cancer
por: Bach, Niklas, et al.
Publicado: (2023) -
Bispecific antibody CD73xEGFR more selectively inhibits the CD73/adenosine immune checkpoint on cancer cells and concurrently counteracts pro-oncogenic activities of CD73 and EGFR
por: Ploeg, Emily Maria, et al.
Publicado: (2023)